Showing results (71-80 of 502) with videos related to

Sort By:
Pageof 51
Neuroepidemiology|February 2, 2011
Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseasesRuth Ann Marrie, Ralph I Horwitz, Gary Cutter, et al.
Neurology|June 20, 2020
Comorbidity is associated with disease activity in MS: Findings from the CombiRx trialAmber Salter, Kaarina Kowalec, Kathryn C Fitzgerald, et al.
Muscle & Nerve|May 15, 2012
Psychometric evaluation of the myasthenia gravis composite using Rasch analysisReza Sadjadi, Mark Conaway, Gary Cutter, et al.
Journal of Biopharmaceutical Statistics|December 19, 2025
The proportional treatment effect: A metric that empowers and connectsGuoqiao Wang, Yijie Liao, Caiyan Li, et al.
International Journal of MS Care|June 3, 2016
Analysis of Diagnoses Associated with Multiple Sclerosis-Related In-Hospital Mortality Using the Premier Hospital DatabaseFrank R Ernst, Jennifer Pocoski, Gary Cutter, et al.
Advances in Therapy|November 22, 2014
No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosisRichard Nixon, Niklas Bergvall, Davorka Tomic, et al.
Journal of the Neurological Sciences|April 2, 2026
Clocks out of sync: Increased epigenetic aging variability in multiple sclerosisFernanda L Schumacher, Gary Cutter, Christin E Burd, et al.
Multiple Sclerosis and Related Disorders|March 20, 2026
Beyond the 2024 McDonald criteria for defining and diagnosing multiple sclerosisGavin Giovannoni, Edward J Thompson, Gary Cutter, et al.
Pageof 51